Losartan: Difference between revisions
ClaireLewis (talk | contribs) (Created page with "==Administration== *Type: Antihypertensive *Dosage Forms: *Routes of Administration: oral *Common Trade Names: Cozaar ==Adult Dosing== *25-150mg PO daily ==Pediatric Dosing=...") |
(Text replacement - " P450" to "P450") |
||
| Line 35: | Line 35: | ||
==Pharmacology== | ==Pharmacology== | ||
*Half-life: 2-6 hours | *Half-life: 2-6 hours | ||
*Metabolism: Hepatic; P450 CYP2C9 and CYP3A4 | *Metabolism: Hepatic;[[P450]] CYP2C9 and CYP3A4 | ||
*Excretion: Fecal, renal | *Excretion: Fecal, renal | ||
Revision as of 13:22, 24 September 2016
Administration
- Type: Antihypertensive
- Dosage Forms:
- Routes of Administration: oral
- Common Trade Names: Cozaar
Adult Dosing
- 25-150mg PO daily
Pediatric Dosing
- 0.1 to 1.4 mg/kg daily
Special Populations
- Pregnancy Rating: D
- Lactation risk: Infant risk cannot be ruled out
- Renal dosing: no adjustment
- Hepatic dosing: starting dose 25mg daily
Contraindications
- Allergy to class/drug
- Concomitant use with aliskiren in diabetes
Adverse Reactions
Serious
- Acute kidney injury
- Rhabdomyolisis
- Syncope
- Stroke
- Angioedema
Common
- Backache
- Dizziness
- Cough, URI symptoms
Pharmacology
- Half-life: 2-6 hours
- Metabolism: Hepatic;P450 CYP2C9 and CYP3A4
- Excretion: Fecal, renal
Mechanism of Action
- Reversible angiotensin II inhibitor